Cue Health and Pfizer Collaborate to Provide COVID Patients with Critical Health Info
Cue Health and Pfizer are collaborating to raise awareness for those with underlying conditions of the risks of progressing to severe COVID.
Read MorePosted by Andy Lundin | Mar 2, 2023 | Covid 19 |
Cue Health and Pfizer are collaborating to raise awareness for those with underlying conditions of the risks of progressing to severe COVID.
Read MorePosted by Chris Wolski | Mar 2, 2023 | Prostate, Unknown Origin & Other Cancer Types |
Veracyte CEO Marc Stapley outlines how single-cancer testing is giving pathologists, clinicians, and patients an edge.
Read MorePosted by Andy Lundin | Mar 1, 2023 | Diagnostic Technologies, Gastrointestinal Infections |
Lucem Health’s new early disease detection solution leverages existing EHR data to identify those at risk of serious or chronic disease.
Read MorePosted by Andy Lundin | Mar 1, 2023 | Cancer, Digital Pathology |
PathGroup will advance its standard of diagnosis for diseases like cancer through Proscia’s Concentriq Dx digital pathology software platform.
Read MorePosted by Chris Wolski | Feb 28, 2023 | Urinalysis & Toxicology |
UTI complications are common for pregnant women and newborns, and is critical to accurately diagnose and treat patients.
Read More